NYSE:OGN
Organon & Co.
Organon & Co.'s revenue fell 2.9% in fiscal 2025 to $6.2B. Free cash flow was $538.0M, 8.7% of revenue, and the diluted share count rose 0.6%.Summary generated from Organon & Co.'s SEC filings. Latest annual report filed Feb 24, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$6.2B
Revenue growth−2.9%
Revenue, 5-yr CAGR−1.0%
Gross margin53.3%
Operating marginn/a
Net margin3.0%
ROICn/a
Return on equity30.6%
Debt / equity11.49
Free cash flow$538.0M
FCF margin8.7%
Share count change+0.6%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6,304 | 6,174 | 6,263 | 6,403 | 6,216 |
| Operating income | n/a | n/a | n/a | n/a | n/a |
| Net income | 1,351 | 917 | 1,023 | 864 | 187 |
| Free cash flow | 1,968 | 662 | 548 | 764 | 538 |
Recent filings
- 4Insider transaction report
Aug 12, 2026 - 4Insider transaction report
Aug 5, 2026 - 8-KRegulation FD disclosure
Jul 31, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Jul 31, 2026 - 8-KResults of a shareholder vote
Jul 23, 2026 - 8-KOther events
Jul 17, 2026 - 8-KDirector or officer change
Jun 11, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 4, 2026